Gene · 60489
APOBEC3G: apolipoprotein B mRNA editing enzyme catalytic subunit 3G
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. APOBEC3G: apolipoprotein B mRNA editing enzyme catalytic subunit 3G. Genes, record 60489. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/60489
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | 384 | 22 | Ensembl, GeneID, HGNC |
Source UniProt
Patents244
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4828972 A1 | 2026-10-28 | 36 | Q9HC16 | Espacenet |
| EP 4828972 A1 | 2026-10-28 | 583 | Q9HC16 | Espacenet |
| EP 4828972 A1 | 2026-10-28 | 629 | Q9HC16 | Espacenet |
| JP 2026525611 A | 2026-07-31 | 68 | Q9HC16 | Espacenet |
| JP 2026525612 A | 2026-07-31 | 501 | Q9HC16 | Espacenet |
| EP 4777618 A1 | 2026-07-22 | 36 | Q9HC16 | Espacenet |
| EP 4777618 A1 | 2026-07-22 | 583 | Q9HC16 | Espacenet |
| EP 4777618 A1 | 2026-07-22 | 629 | Q9HC16 | Espacenet |
| JP 2026116287 A | 2026-07-09 | 272 | Q9HC16 | Espacenet |
| EP 4762095 A1 | 2026-06-24 | 36 | Q9HC16 | Espacenet |
1 to 10 of 244
See all 244 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,647
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APOBEC3G papers | Newest fiscal year |
|---|---|---|---|
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 41 | 2025 |
| ZIAAI000669 | Molecular Analysis Of Retroviral Genes And Their Products | 35 | 2025 |
| T32AI083196 | Minnesota Training Program in Virology | 31 | 2025 |
| ZIABC010595 | Structure and Function of Vif and APOBEC3 (A3) Proteins | 25 | 2025 |
| P01CA234228 | APOBEC Mutagenesis in Cancer | 23 | 2025 |
| T32CA009138 | Molecular, Genetic and Cellular Targets of Cancer Training Program | 20 | 2025 |
| P30AI094189 | The Johns Hopkins Center for AIDS Research (JHU CFAR) | 19 | 2025 |
| P30AI060354 | Harvard University Center for AIDS Research | 14 | 2025 |
| ZIABC010504 | Understanding Retroviral Reverse Transcription, Recombination, and Replication | 12 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
1 to 10 of 2,647Source NIH's project files
See all 2,647 nih grantsPapers3,812
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural Adaptability in HIV-2 Vif Drives Broad Antagonism of APOBEC3G. | bioRxiv | 2026 | 42818250 | PubTator, text mining | PubMed |
| Deubiquitinase USP8 inhibits HIV-1 replication by suppressing Tat-mediated viral transactivation. | J Virol | 2026 | 42803586 | PubTator, text mining | PubMed |
| Multiscale Transcriptomic and Molecular Modeling Analyses Suggest DCPMU-Associated Epithelial Remodeling and Tumor Microenvironment Perturbation in Prostate Cancer. | Curr Issues Mol Biol | 2026 | 42793291 | PubTator, text mining | PubMed |
| Engineered Transformer Base Editor with Enhanced Editing Efficiency. | Adv Sci (Weinh) | 2026 | 42723179 | PubTator, text mining | PubMed |
| The Innate Antiviral Factors APOBEC3G and APOBEC3H Interact with the Nucleocapsids of Human Coronaviruses in an RNA-Dependent Manner. | Viruses | 2026 | 42655650 | PubTator, text mining | PubMed |
| Structural Basis of Intermolecular Interactions Between APOBEC3 and HIV-1 Vif. | Viruses | 2026 | 42515639 | PubTator, text mining | PubMed |
| Strain-specific epistasis shapes fitness landscapes of APOBEC3G antagonism by HIV-1 Vif proteins. | Sci Adv | 2026 | 42490454 | PubTator, text mining | PubMed |
| Integrated immune profiling identifies a coordinated T-cell activation and inflammatory signature in SLE. | Lupus Sci Med | 2026 | 42457337 | PubTator, text mining | PubMed |
| Human APOBEC3G suppresses homologous recombination and LIG4-independent end joining in DNA double-strand break repair. | FEBS J | 2026 | 42403051 | PubTator, text mining | PubMed |
| Full-length structure of the anti-viral and pro-tumor DNA deaminase APOBEC3B. | bioRxiv | 2026 | 42367898 | PubTator, text mining | PubMed |
1 to 10 of 3,812
See all 3,812 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/60489
GET https://conductscience.org/api/genes/v1/60489/patents?page=2